Sunday, 28 May 2023
Trending

Investing

Oppenheimer upgrades Mirati Therapeutics to 'outperform' with a price target of $56.00

Oppenheimer upgrades Mirati Therapeutics to 'outperform' with a price target of $56.00



Oppenheimer upgrades Mirati Therapeutics to 'outperform' with a price target of $56.00

Click Here to Read the Full Original Article at All News…